Unbiased AI-powered news
16 stories related to this topic, newest first.
en.rfi.frThe French healthcare system has started reimbursing Wegovy and Mounjaro for eligible patients. France reports obesity rates lower than many EU countries yet still faces regional variation in prevalence.
NprAnalyses presented at the May 2026 American Society of Clinical Oncology meeting found reduced cancer incidence and progression among patients taking GLP-1 obesity treatments.
qz.comPatients lost 13 percent of body weight on the highest dose after 76 weeks. Liver-fat reduction exceeded placebo by a wide margin.
Boehringer Ingelheim’s weekly injectable reduced liver fat more than placebo but produced 13 percent weight loss after 76 weeks, below rates for Wegovy and Zepbound.
theconversation.comNorwegian researchers found participants on a 16-week rapid calorie restriction plan lost more weight at 12 months than those on a slower reduction. Both groups followed the same 36-week maintenance phase afterward.
sciencemediacentre.co.nzUniversity of Oklahoma researchers identified cellular and enzymatic differences in breast tumors from women with obesity. The findings may help explain higher rates of invasive disease in this group.
EuronewsFrance will cover 65 percent of the cost of Wegovy and Mounjaro for obesity patients from 15 June, becoming the first European country to add the drugs to standard national health coverage.
indianexpress.comA new deep-learning framework called MouseMapper analyzes disease effects across all organ systems in mice at cellular resolution. Researchers applied the tool to diet-induced obesity and identified nerve and immune-cell alterations.
swissinfo.chA new deep-learning framework called MouseMapper analyzes entire mouse bodies at the cellular level. The model maps nerves and immune cells across 31 organs and tissues. Researchers applied it to study diet-induced obesity and identified nerve changes linked to sensory deficits.
ForbesA new analysis quantifies how packaging releases microplastics and chemicals into food, while a separate global study shows obesity rates plateauing in some high-income nations but accelerating in many others. Research on coffee also links both caffeinated and decaffeinated varie…
news-medical.netA Nature paper published by the NCD Risk Factor Collaboration shows the speed of obesity increase was greater in 2024 than any prior year since 1980 for women in 84 countries and men in 109. Rates have leveled off in most high-income nations and appear to be declining in France,…
english.elpais.comA global study led by Imperial College London found that obesity rates in the UK have stabilised in children since the early 2000s and are rising more slowly among adults. The analysis of data from 1980 to 2024 shows the UK remains among the top 10 high-income western nations for…
indiatoday.intoday.inScientific understanding of body fat has shifted from viewing it as inert storage to recognizing it as a complex organ. Fat tissue releases hormones, communicates via nerves and immune cells, and influences appetite, metabolism, mood, fertility and immunity. The reassessment is c…
theconservativetreehouse.comPresident Donald Trump and the Centers for Medicare & Medicaid Services unveiled an 18-month pilot that will allow qualifying Medicare Part D beneficiaries to obtain certain GLP-1 medications such as Wegovy for $50 a month beginning July 1, 2026. The program marks a major policy…
New York PostA review of studies presented at the European Congress on Obesity found that increasing to about 8,500 steps per day during and after weight loss programs helped participants sustain most of their weight reduction. The 10,000-step target originated as a 1960s Japanese pedometer m…
EuronewsA new analysis of 14 clinical trials shows that participants who increased their daily steps to around 8,500 during weight loss and maintenance phases sustained an average 3.28 percent reduction in body weight. The research, involving nearly 4,000 overweight or obese adults, was…